7Baggers
 Novocure to Report Third Quarter 2025 Financial Results  Yahoo Finance Wed, 01 Oct 2025 11:00:00 GMT
 NovoCure stock rating reiterated at Buy by H.C. Wainwright on METIS trial data  Investing.com Nigeria Tue, 30 Sep 2025 12:41:35 GMT
 novocure's (nvcr) "neutral" rating reaffirmed at wedbush  MarketBeat Tue, 30 Sep 2025 12:28:03 GMT
 Novocure’s cancer therapy delays brain metastases progression By Investing.com  Investing.com Nigeria Tue, 30 Sep 2025 03:33:25 GMT
 Novocure (NVCR) Announces Positive Phase 3 METIS Trial Results  GuruFocus Mon, 29 Sep 2025 20:53:58 GMT
 42,600 shares in novocure limited $nvcr purchased by strs ohio  MarketBeat Wed, 24 Sep 2025 04:18:10 GMT
 42,600 shares in novocure limited $nvcr purchased by strs ohio  MarketBeat Tue, 23 Sep 2025 07:00:00 GMT
 42,600 shares in novocure limited $nvcr bought by strs ohio  MarketBeat Tue, 23 Sep 2025 03:50:50 GMT
 strs ohio purchases shares of 42,600 novocure limited $nvcr  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 strs ohio invests $759,000 in novocure limited $nvcr  MarketBeat Sat, 20 Sep 2025 07:09:04 GMT
 is novocure (nasdaq:nvcr) weighed on by its debt load?  富途牛牛 Thu, 18 Sep 2025 12:11:11 GMT
 Novocure obtains approval for Optune Lua device in Japan to treat NSCLC  Medical Device Network Tue, 16 Sep 2025 07:00:00 GMT
 novocure’s electric fields device approved for treating lung cancer in japan  Mugglehead Magazine Tue, 16 Sep 2025 05:26:15 GMT
 union pacific, corteva, novocure  TradingView Mon, 15 Sep 2025 13:09:15 GMT
 novocure up after japan approves lung cancer treatment  TradingView Mon, 15 Sep 2025 12:30:56 GMT
 Novocure earns Japanese approval for tumor-treating fields  MassDevice Mon, 15 Sep 2025 11:48:26 GMT
 Novocure Announces Approval For Optune Lua In Japan  Nasdaq Mon, 15 Sep 2025 07:00:00 GMT
 novocure’s electric fields device approved for treating lung cancer in japan  Mugglehead Magazine Mon, 15 Sep 2025 07:00:00 GMT
 novocure (nvcr) gains approval in japan for cancer treatment  GuruFocus Mon, 15 Sep 2025 07:00:00 GMT
 novocure gains approval for optune lua in japan  TipRanks Mon, 15 Sep 2025 07:00:00 GMT
 novocure limited $nvcr shares sold by teza capital management llc  MarketBeat Mon, 15 Sep 2025 03:10:15 GMT
 novocure (nasdaq:nvcr) ceo ashley cordova purchases 81,550 shares  MarketBeat Fri, 12 Sep 2025 07:00:00 GMT
 insider spends us$997k buying more shares in novocure  Yahoo Finance Thu, 11 Sep 2025 11:10:04 GMT
 novocure limited $nvcr shares sold by hsbc holdings plc  MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
 novocure (nasdaq:nvcr) shares gap up after insider buying activity  MarketBeat Wed, 10 Sep 2025 15:18:44 GMT
 novocure (nasdaq:nvcr) shares gap up on insider buying activity  MarketBeat Wed, 10 Sep 2025 15:18:44 GMT
 novocure (nasdaq:nvcr) ceo ashley cordova purchases 81,550 shares  MarketBeat Wed, 10 Sep 2025 14:54:40 GMT
 hsbc holdings plc sells 37,369 shares of novocure limited $nvcr  MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
 novocure at h.c. wainwright: strategic growth in cancer treatment  Investing.com Tue, 09 Sep 2025 20:20:19 GMT
 novocure ceo makes bold stock purchase!  TipRanks Tue, 09 Sep 2025 02:10:36 GMT
 novocure ceo cordova buys shares worth $996k by investing.com  Investing.com South Africa Mon, 08 Sep 2025 11:21:19 GMT
 NovoCure Limited Stock (NVCR) Opinions on FDA Approval of Optune Lua Device  Quiver Quantitative Mon, 08 Sep 2025 07:00:00 GMT
 Novocure CEO Cordova buys shares worth $996k  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 novocure ceo makes bold stock purchase!  TipRanks Mon, 08 Sep 2025 07:00:00 GMT
 novocure limited $nvcr shares purchased by palo alto investors lp  MarketBeat Sat, 06 Sep 2025 16:07:30 GMT
 invesco ltd. sells 87,927 shares of novocure limited $nvcr  MarketBeat Fri, 05 Sep 2025 07:00:00 GMT
 why novocure stock is cratering today  MSN Thu, 04 Sep 2025 15:23:19 GMT
 published on: 2025-09-04 03:04:02  Newser Thu, 04 Sep 2025 08:04:02 GMT
 published on: 2025-08-31 17:52:32  Newser Sun, 31 Aug 2025 22:52:32 GMT

NovoCure Limited
(NASDAQ:NVCR) 

NVCR stock logo

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and Optune Lua, a Tumor Treating Fields delivery system for use as a monotherapy treatment for adult patients wit...

Founded: 2000
Full Time Employees: 782
CEO: Asaf Danziger  
Sector: Healthcare
Industry: Medical Instruments & Supplies
blind

Share this website to your friends